Histologic malignancy grading of invasive ductal breast carcinoma. A regression analysis of prognostic factors in low-risk carcinomas from a multicenter trial
- PMID: 3040213
- DOI: 10.1002/1097-0142(19870915)60:6<1299::aid-cncr2820600623>3.0.co;2-l
Histologic malignancy grading of invasive ductal breast carcinoma. A regression analysis of prognostic factors in low-risk carcinomas from a multicenter trial
Abstract
In a prospective adjuvant trial including patients with primary operable breast cancer, invasive carcinomas of ductal type were subjected to histological malignancy grading. The parameters investigated were tubule formation, number of mitoses and cell pleomorphism. A Cox regression model for survival data was applied to evaluate the impact of the histological parameters on prognosis in 1809 patients with low-risk carcinomas. Cell pleomorphism proved superior to the other histologic tumor characteristics. It was found that low-risk invasive ductal carcinomas with severe cell pleomorphism had an excess recurrence intensity of 209% relative to carcinomas with no pleomorphism. It is therefore suggested that polymorphous invasive ductal breast carcinomas, other things being equal, should be regarded as high-risk tumors in future clinical trials. Finally it was found that the tripartite malignancy grading 1, 2 and 3 characterizing each of the histological parameters was not equidistant. Consequently, the traditional tripartite histologic scoring needs reconsideration.
Similar articles
-
Proliferating cell nuclear antigen in breast carcinomas. An immunohistochemical study with correlation to histopathological features and prognostic factors.Virchows Arch. 1994;424(1):39-46. doi: 10.1007/BF00197391. Virchows Arch. 1994. PMID: 7981902
-
Back to Basics: Traditional Nottingham Grade Mitotic Counts Alone are Significant in Predicting Survival in Invasive Breast Carcinoma.Ann Surg Oncol. 2015 Dec;22 Suppl 3:S509-15. doi: 10.1245/s10434-015-4616-y. Epub 2015 May 22. Ann Surg Oncol. 2015. PMID: 26001860
-
Expression of glycodelin protein and mRNA in human ductal breast cancer carcinoma in situ, invasive ductal carcinomas, their lymph node and distant metastases, and ductal carcinomas with recurrence.Oncol Rep. 2005 Mar;13(3):413-9. Oncol Rep. 2005. PMID: 15706409
-
Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.APMIS Suppl. 2003;(108):1-67. APMIS Suppl. 2003. PMID: 12874968 Review.
-
Optimal management of ductal carcinoma in situ of the breast.Surg Oncol. 2003 Dec;12(4):221-40. doi: 10.1016/S0960-7404(03)00031-8. Surg Oncol. 2003. PMID: 14998563 Review.
Cited by
-
Nuclear characteristics as indicators of prognosis in node negative breast cancer patients.Breast Cancer Res Treat. 1989 Nov;14(2):207-16. doi: 10.1007/BF01810737. Breast Cancer Res Treat. 1989. PMID: 2605347
-
Histological grade and steroid receptor content of primary breast cancer--impact on prognosis and possible modes of action.Br J Cancer. 1988 Oct;58(4):480-6. doi: 10.1038/bjc.1988.245. Br J Cancer. 1988. PMID: 3207602 Free PMC article.
-
The prognostic effect of histological tumor grade in node-negative breast cancer patients.Breast Cancer Res Treat. 1993;25(3):235-45. doi: 10.1007/BF00689838. Breast Cancer Res Treat. 1993. PMID: 8369525 Clinical Trial.
-
Clinicopathologic features associated with long-term survival in node-negative breast cancer patients.Surg Today. 1996;26(2):105-14. doi: 10.1007/BF00311773. Surg Today. 1996. PMID: 8919280
-
Medullary carcinoma of the breast, proposal for a new simplified histopathological definition. Based on prognostic observations and observations on inter- and intraobserver variability of 11 histopathological characteristics in 131 breast carcinomas with medullary features.Br J Cancer. 1991 Apr;63(4):591-5. doi: 10.1038/bjc.1991.137. Br J Cancer. 1991. PMID: 2021545 Free PMC article.
MeSH terms
LinkOut - more resources
Medical